FDA Warns Terbutaline Should Not Be Used in Pregnant Women for Prevention or Treatment of Preterm Labor

In late February, the FDA warned the public that injectable terbutaline should not be used in pregnant women for prevention or prolonged treatment (beyond 48-72 hours) of preterm labor in either the hospital or outpatient setting because of the potential for serious maternal heart problems (e.g., cardiac arrhythmias, myocardial infarction, pulmonary edema, hypertension, and tachycardia),… Learn More »